Detection of cytomegalovirus (CMV) proteins in hematopoietic stem cell transplantation (HSCT) patients by flow cytometry.

被引：0
|
作者：
Detrick, B
Hooks, JJ
Keiser, J
Tabbara, I
机构：
[1] GEORGE WASHINGTON UNIV,SCH MED,WASHINGTON,DC
[2] NEI,NIH,BETHESDA,MD 20892
来源：
BLOOD | 1996年 / 88卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1687 / 1687
页数：1
相关论文
共 50 条
  • [31] CMV reactivation in pediatric hematopoietic stem cell transplantation
    Yoon, Hoi Soo
    Seo, Jong Jin
    Choi, Eun Seok
    Song, Joon Sup
    Im, Ho Joon
    Moon, Hyung Nam
    Park, Chan Jeoung
    Chi, Hyun Sool
    PEDIATRIC BLOOD & CANCER, 2007, 49 (04) : 502 - 502
  • [32] EFFICACY AND SAFETY OF CMV-SPECIFIC T CELL LINE (CMV-TCL) FOR CMV REACTIVATIONS IN HIGH RISK ADULT PATIENTS (PTS) AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)
    Bramanti, S.
    Comoli, P.
    Vai, A.
    Crocchiolo, R.
    Sarina, B.
    Basso, S.
    Mineri, R.
    Santoro, A.
    Castagna, L.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S336 - S336
  • [33] Investigation of Cytomegalovirus, Epstein-Barr Virus and Adenovirus Infections After Hematopoietic Stem Cell Transplantation (HSCT) in Pediatric Patients
    Kaya, Nazli Nida
    Kupeli, Serhan
    Ozturk, Gokhan
    Bayram, Ibrahim
    Ozdogru Sagdic, Deniz
    Sezgin, Gulay
    Koksal, Fatih
    Yarkin, Fugen
    FLORA-INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI, 2018, 23 (01): : 15 - 24
  • [34] Incidence and Risk Factors for Cytomegalovirus (CMV) Reactivation Following Autologous Hematopoietic Stem Cell Transplantation in Children
    Hussein, Ayad Ahmed
    Al-Antary, Eman T.
    Najjar, Rula
    Al-Hamdan, Dua'a S.
    Al-Zaben, Abdulhadi
    Frangoul, Haydar
    PEDIATRIC BLOOD & CANCER, 2015, 62 (06) : 1099 - 1101
  • [35] Cytomegalovirus (CMV) infection after hematopoietic stem cell transplantation: significant progress, but many unresolved problems
    Busca, Alessandro
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2009, 9 (04) : 383 - 385
  • [36] Clinical significance of cytomegalovirus (CMV) antigenemia in the prediction and diagnosis of CMV gastrointestinal disease after allogeneic hematopoietic stem cell transplantation
    Mori, T
    Mori, S
    Kanda, Y
    Yakushiji, K
    Mineishi, S
    Takaue, Y
    Gondo, H
    Harada, M
    Sakamaki, H
    Yajima, T
    Iwao, Y
    Hibi, T
    Okamoto, S
    BONE MARROW TRANSPLANTATION, 2004, 33 (04) : 431 - 434
  • [37] Clinical significance of cytomegalovirus (CMV) antigenemia in the prediction and diagnosis of CMV gastrointestinal disease after allogeneic hematopoietic stem cell transplantation
    T Mori
    S Mori
    Y Kanda
    K Yakushiji
    S Mineishi
    Y Takaue
    H Gondo
    M Harada
    H Sakamaki
    T Yajima
    Y Iwao
    T Hibi
    S Okamoto
    Bone Marrow Transplantation, 2004, 33 : 431 - 434
  • [38] Foscarnet vs ganciclovir for cytomegalovirus (CMV) antigenemia after allogeneic hemopoietic stem cell transplantation (HSCT):: a randomised study
    Moretti, S
    Zikos, P
    Van Lint, MT
    Tedone, E
    Occhini, D
    Gualandi, F
    Lamparelli, T
    Mordini, N
    Berisso, G
    Bregante, S
    Bruno, B
    Bacigalupo, A
    BONE MARROW TRANSPLANTATION, 1998, 22 (02) : 175 - 180
  • [39] Foscarnet vs ganciclovir for cytomegalovirus (CMV) antigenemia after allogeneic hemopoietic stem cell transplantation (HSCT): a randomised study
    S Moretti
    P Zikos
    MT Van Lint
    E Tedone
    D Occhini
    F Gualandi
    T Lamparelli
    N Mordini
    G Berisso
    S Bregante
    B Bruno
    A Bacigalupo
    Bone Marrow Transplantation, 1998, 22 : 175 - 180
  • [40] Evaluation of cytomegalovirus (CMV) reactivation, relapse, and survival after allogeneic hematopoietic stem cell transplantation (allo-HSCT) using two T cell depletion strategies.
    Hilal, Talal
    Peterson, Shawn
    Bodine, Charles
    Slone, Stacey A.
    Hildebrandt, Gerhard
    Gul, Zartash
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345